Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Mark Fogg, Ph.D.

Group Leader Immunology at Abzena

Profile

Mark Fogg, Ph.D., leads the Immunology Group at Abzena, a company that enables the development and manufacture of better biopharmaceuticals. Mark obtained his PhD in T cell immunology at the University of Reading, and carried out his postdoctoral work on the generation of T cells for cancer immunotherapy at Harvard Medical School. He then migrated to industry to lead a cell biomarker discovery group within Pfizer BioTX R&D prior to joining Abzena where he leads the effort to understand immunogenicity risk associated with biotherapeutics.

Mark Fogg, Ph.D., leads the Immunology Group at Abzena, a company that enables the development and manufacture of better biopharmaceuticals. Mark obtained his PhD in T cell immunology at the University of Reading, and carried out his postdoctoral work on the generation of T cells for cancer immunotherapy at Harvard Medical School. He then migrated to industry to lead a cell biomarker discovery group within Pfizer BioTX R&D prior to joining Abzena where he leads the effort to understand immunogenicity risk associated with biotherapeutics.

Agenda Sessions